Oscar Health, Inc. (NYSE:OSCR – Get Free Report) was the recipient of some unusual options trading on Monday. Traders bought 13,088 put options on the stock. This represents an increase of 60% compared to the typical daily volume of 8,163 put options.
Institutional Investors Weigh In On Oscar Health
Several large investors have recently modified their holdings of OSCR. Tower Research Capital LLC TRC boosted its stake in shares of Oscar Health by 171.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock worth $89,000 after acquiring an additional 4,185 shares in the last quarter. KBC Group NV boosted its position in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health in the fourth quarter worth $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health in the fourth quarter worth $138,000. Finally, Virtu Financial LLC acquired a new stake in shares of Oscar Health in the fourth quarter worth $140,000. 75.70% of the stock is owned by institutional investors.
Oscar Health Price Performance
Shares of OSCR stock traded down $0.26 during mid-day trading on Monday, hitting $12.97. 2,686,673 shares of the stock traded hands, compared to its average volume of 3,617,608. Oscar Health has a twelve month low of $12.43 and a twelve month high of $23.79. The firm has a market cap of $3.25 billion, a price-to-earnings ratio of -648.18 and a beta of 1.75. The company’s 50-day simple moving average is $15.21 and its 200-day simple moving average is $16.38. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.
Wall Street Analyst Weigh In
Several analysts recently commented on OSCR shares. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Wells Fargo & Company cut Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $20.00 to $16.00 in a research report on Thursday. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $20.19.
Check Out Our Latest Stock Analysis on OSCR
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
- Five stocks we like better than Oscar Health
- Investing In Automotive Stocks
- Super Micro’s International Presence Makes It a Winning Stock
- 5 discounted opportunities for dividend growth investors
- Grocery Outlet Insider and Institutional Buyers Signal Bottom
- Are Penny Stocks a Good Fit for Your Portfolio?
- Consumers Are Cutting Back, But These 3 Stocks Will Stay Strong
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.